IL165969A0 - Medium for culturing aurologous human progenitor stem cells and applications thereof - Google Patents

Medium for culturing aurologous human progenitor stem cells and applications thereof

Info

Publication number
IL165969A0
IL165969A0 IL16596904A IL16596904A IL165969A0 IL 165969 A0 IL165969 A0 IL 165969A0 IL 16596904 A IL16596904 A IL 16596904A IL 16596904 A IL16596904 A IL 16596904A IL 165969 A0 IL165969 A0 IL 165969A0
Authority
IL
Israel
Prior art keywords
aurologous
culturing
applications
medium
stem cells
Prior art date
Application number
IL16596904A
Other languages
English (en)
Original Assignee
Jean Carlos Chacques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean Carlos Chacques filed Critical Jean Carlos Chacques
Publication of IL165969A0 publication Critical patent/IL165969A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • C12N5/0659—Satellite cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C12N2501/91—Heparin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16596904A 2002-07-02 2004-12-23 Medium for culturing aurologous human progenitor stem cells and applications thereof IL165969A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200201540A ES2198216B1 (es) 2002-07-02 2002-07-02 Medio de cultivo de celulas madre-progenitoras autologas humanas y sus aplicaciones.
PCT/ES2003/000285 WO2004005494A1 (es) 2002-07-02 2003-06-11 Medio de cultivo de células madre-progenitoras autólogas humanas y sus aplicaciones

Publications (1)

Publication Number Publication Date
IL165969A0 true IL165969A0 (en) 2006-01-15

Family

ID=30011351

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16596904A IL165969A0 (en) 2002-07-02 2004-12-23 Medium for culturing aurologous human progenitor stem cells and applications thereof

Country Status (13)

Country Link
US (1) US20060110368A1 (es)
EP (1) EP1972684A1 (es)
JP (1) JP5379340B2 (es)
KR (2) KR100960173B1 (es)
CN (1) CN100572527C (es)
AU (1) AU2003240857B2 (es)
BR (1) BR0312365A (es)
ES (1) ES2198216B1 (es)
IL (1) IL165969A0 (es)
MX (1) MXPA04012601A (es)
NZ (1) NZ537397A (es)
RU (1) RU2312141C2 (es)
WO (1) WO2004005494A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253735B2 (en) 2003-03-24 2007-08-07 Alien Technology Corporation RFID tags and processes for producing RFID tags
DE102004025684A1 (de) 2004-04-29 2005-11-17 Osram Opto Semiconductors Gmbh Optoelektronischer Halbleiterchip und Verfahren zum Ausbilden einer Kontaktstruktur zur elektrischen Kontaktierung eines optoelektronischen Halbleiterchips
EP2206724A1 (en) * 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor
CA2699236C (en) 2007-09-11 2017-02-28 Sapporo Medical University Cell growth method and pharmaceutical preparation for tissue repair and regeneration
BRPI0909515A2 (pt) * 2008-03-28 2015-08-11 Labo Juversa Co Ltd Agente para tratamento de envelhecimento e cicatrizes de pele
RU2493250C2 (ru) * 2011-07-08 2013-09-20 Общество с ограниченной ответственностью Научно-производственное предприятие "ПанЭко" Малосывороточная среда для культивирования фибробластов человека
JP5598864B2 (ja) * 2011-12-05 2014-10-01 北海道公立大学法人 札幌医科大学 細胞増殖方法ならびに組織の修復および再生のための医薬
RU2506309C2 (ru) * 2012-03-11 2014-02-10 Екатерина Алексеевна Федорова Способ культивирования миобластов in vitro для получения биомассы миоцитов для пищевых целей
TWI643953B (zh) * 2014-12-11 2018-12-11 訊聯生物科技股份有限公司 以自體血漿培養原始細胞的方法
CN106110304A (zh) * 2016-07-28 2016-11-16 广州赛莱拉干细胞科技股份有限公司 一种祛疤组合物和敷料
KR102093810B1 (ko) * 2017-09-19 2020-03-26 서울대학교산학협력단 면역원성 감소 방법
CA3137836C (en) * 2019-04-23 2024-04-09 Cellatoz Therapeutics, Inc. Method for regulation of selective differentiation of musculoskeletal stem cells
CN112501035B (zh) * 2020-12-09 2022-09-20 云南大学 基于捕食线虫真菌细胞膜破裂和内体增多而产生捕食器官的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735726A (en) * 1981-07-22 1988-04-05 E. I. Du Pont De Nemours And Company Plasmapheresis by reciprocatory pulsatile filtration
US4668399A (en) * 1982-02-16 1987-05-26 E. I. Du Pont De Nemours And Company Hollow fiber plasmapheresis process
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
NL9101680A (nl) * 1991-10-04 1993-05-03 Tno Werkwijze voor het genetisch modificeren van beenmergcellen van primaten, alsmede daarbij bruikbare cellen die recombinante retrovirale vectoren produceren.
JPH06113829A (ja) * 1992-10-09 1994-04-26 Tabai Espec Corp 動物細胞培地添加血清の調製方法、動物細胞培地の調製方法及び培養装置
US5728581A (en) * 1995-06-07 1998-03-17 Systemix, Inc. Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
NZ337945A (en) * 1997-03-18 2001-10-26 Introgene B Combining primate bone marrow cells with a recombinant retrovirus using a physical means to bring them into close physical contact
AU756490B2 (en) * 1997-08-26 2003-01-16 Abgenix, Inc. A process for inhibiting complement activation via the alternative pathway
US6962698B1 (en) * 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
US6624141B1 (en) * 1999-03-17 2003-09-23 The Regents Of The University Of Michigan Protamine fragment compositions and methods of use
JP2003505475A (ja) * 1999-07-23 2003-02-12 ダイアクリン インク 筋細胞、及び心臓修復におけるそれらの利用
US7015037B1 (en) * 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US20020124855A1 (en) * 2001-03-12 2002-09-12 Chachques Juan C. Method of providing a dynamic cellular cardiac support
US20030044766A1 (en) * 2001-08-29 2003-03-06 Anne Scholz Methods and devices for detecting cell-cell interactions

Also Published As

Publication number Publication date
CN100572527C (zh) 2009-12-23
EP1972684A1 (en) 2008-09-24
ES2198216A1 (es) 2004-01-16
AU2003240857A1 (en) 2004-01-23
AU2003240857B2 (en) 2008-06-26
KR20050037549A (ko) 2005-04-22
WO2004005494A1 (es) 2004-01-15
KR20080091874A (ko) 2008-10-14
RU2005102061A (ru) 2005-10-10
BR0312365A (pt) 2005-04-05
JP2005531322A (ja) 2005-10-20
MXPA04012601A (es) 2005-09-30
ES2198216B1 (es) 2005-04-16
CN1665922A (zh) 2005-09-07
RU2312141C2 (ru) 2007-12-10
US20060110368A1 (en) 2006-05-25
KR100960173B1 (ko) 2010-05-26
JP5379340B2 (ja) 2013-12-25
NZ537397A (en) 2008-09-26

Similar Documents

Publication Publication Date Title
EP1562636A4 (en) MESENCHYMAL STEM CELLS AND METHODS OF USE
PT2457999T (pt) Sistema de cultura para células estaminais pluripotentes
HK1090086A1 (en) Modulation of stem and progenitor cell differentiation, assays, and uses thereof
AU2003217350A1 (en) Proliferated cell lines and uses thereof
EP1689854A4 (en) PLACENTAR STEM CELLS AND USES THEREOF
EP1775341A4 (en) METHOD FOR INDUCING DIFFERENTIATION OF AMNIOTIC CELLS, AND USE THEREOF
AU2003216058A8 (en) Mammalian neural stem cells, compositions and uses thereof
AU2003221173A1 (en) Placenta-origin mesenchymal cells and medicinal use thereof
AU2002325758A1 (en) Cultured stromal cells and uses thereof
IL165969A0 (en) Medium for culturing aurologous human progenitor stem cells and applications thereof
EP1689377A4 (en) STEM CELL CULTURE MEDIUM AND METHOD FOR THE USE OF THIS MEDIUM AND CELLS
AU2003216822A8 (en) Stem cell culture
EP1557461A4 (en) COMPOSITION FOR THE CULTURE OF PLURIPOTENT STEM CELLS AND THE USE THEREOF
EP1581637A4 (en) MATERIALS AND METHODS WITH HUMAN STEM CELLS
EP1464698A4 (en) HUMAN CELL CULTURE MEDIUM AND CULTIVATION PROCESS
HK1126815A1 (en) Entrapped stem cells and uses thereof
EP1650301A4 (en) THE RE-IDENTIFICATION OF A PLANT AWARDING GENE AND USE THEREOF
EP1685237A4 (en) NEW MULTIPOTENT STEM CELLS
AU2003260815A8 (en) Method for the rapid assessment of the presence and viability of bacterial cells and use thereof________________________
AU2003239778A8 (en) Plant deoxyribonucleoside kinase enzymes and their use
EP1563073A4 (en) PROTEIN PRODUCTION METHODS AND MODIFIED CELLS FOR USE IN SUCH METHODS
EP1636341A4 (en) STEM CELLS FOR CLINICAL AND COMMERCIAL APPLICATIONS
GB0324270D0 (en) Improved control of ES cell self-renewal and lineage specification, and medium therefor
ZA200408367B (en) Modulation of stem and progenitor cell differentiation, assays, and uses thereof
GB2394477B (en) Cell culture